Effects of Viral Reactivation on Outcomes of Brain-injured Patients ( IBIS-VIRUS)

NCT02003196 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 375

Last updated 2021-08-25

No results posted yet for this study

Summary

Morbidity and mortality of ICU patients is increased by the development of a "immunosuppression" systemic (IS). This IS develops in the early hours of hospitalization and is responsible for severe infections, including viral reactivations (Cytomegalovirus or Herpes Simplex Virus). Viral reactivation was associated with increased morbidity and mortality in intensive care units. In clinical practice, they are searched at the onset of organ failure or unexplained fever. The investigators wish to conduct this research in the stroke patients to assess the predictive power of these viral reactivations on the duration of mechanical ventilation.

Conditions

  • Brain Injury

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Karim Asehnoune, Pr · Nantes University Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-05
Primary Completion
2020-03-26
Completion
2020-03-26

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02003196 on ClinicalTrials.gov